US Broker Ratings

BrightSpring Health Services (BTSG) Stock Analysis: A Promising 29.99% Upside in the Healthcare Sector

BrightSpring Health Services, Inc. (BTSG) stands poised at the forefront of the healthcare sector, offering investors an intriguing opportunity with a potential upside of 29.99%. With a market capitalization of..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Evaluating a 51.72% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at an intriguing crossroads for investors focusing on the biotechnology sector. With a significant market cap of $9.65 billion, Ionis presents a unique investment..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating a 13.17% Potential Upside Amid Market Challenges

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) is a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With its headquarters in Hyderabad, India, Dr...

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Challenges in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $4.3 billion, the company operates..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, has been garnering attention for its innovative solutions in diagnostic and therapeutic products. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 14.15% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors seeking exposure to the healthcare sector. As a prominent player in the medical care facilities industry, UHS operates..

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98

Avantor, Inc. (NYSE: AVTR) is a key player in the healthcare sector, focusing on medical instruments and supplies. With a market capitalization of $10.13 billion, Avantor offers a comprehensive range..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with Strong Dividend Yield and Exciting Growth Prospects

Novo Nordisk A/S (NVO), a powerhouse in the healthcare sector, is a Danish company that has carved a niche in the global pharmaceutical landscape, especially in the realm of diabetes..

Teleflex Incorporated (TFX): Stock Analysis Highlights a Promising 10.98% Upside Potential

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, stands as an intriguing prospect for investors seeking exposure to the medical instruments and supplies industry. With a market capitalization..

The Cigna Group (CI) Stock Analysis: Uncovering a Potential 20.85% Upside Amid Robust Growth and Favorable Analyst Ratings

The Cigna Group (CI), a stalwart in the healthcare sector, offers investors a compelling opportunity, particularly when considering its promising upside potential of 20.85%. As a key player in the..

Quest Diagnostics (DGX) Stock Analysis: Insights into a Healthcare Leader with Robust Growth Prospects

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of $26.17 billion, Quest Diagnostics..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 22.66% Upside Potential

Takeda Pharmaceutical Company L (NYSE: TAK), a stalwart in the healthcare sector, is positioned at a critical juncture with promising upside potential for investors. As a leading player in the..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is gaining traction in the biotechnology sector, captivating investors with its cutting-edge therapeutics for B-cell mediated diseases. Based in Morrisville, North Carolina, the company is..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Potential 45.77% Upside Amid Robust Pipeline

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector with a market capitalization of $14.63 billion. Known for its focus on genetic diseases, the company is making headlines..

Natera, Inc. (NTRA) Stock Analysis: A $47.31 Billion Healthcare Innovator with Strong Buy Ratings

Natera, Inc. (NTRA) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $47.31 billion, this Austin-based company has captured the..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 24% Potential Upside in the Healthcare Giant

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector with a rich history dating back to 1891, offers intriguing prospects for investors looking to tap into the medical..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating the Prospects with a 4.25% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, captures investor interest with a robust market capitalization of $187.23 billion. As a leading biopharmaceutical company, Gilead is..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 39% Potential Upside in Healthcare

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, is headquartered in Barcelona, Spain, and has carved out a substantial niche in the drug manufacturing industry. Specializing in plasma-derived..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating the 6.05% Dividend Yield and Its Implications for Investors

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector and a leading player in the global biopharmaceutical industry, continues to capture investor attention with its robust dividend yield and..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 36% Upside Potential with Robust Revenue Growth

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, stands out for its robust financial health and promising growth trajectory. Specializing in the development and commercialization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds